|
JAK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.8953000003914E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.3467999999991E-05 |
| Normal-vs-Stage2 |
9.639500E-03 |
| Normal-vs-Stage3 |
2.201700E-02 |
| Normal-vs-Stage4 |
2.777400E-01 |
| Stage1-vs-Stage2 |
9.397600E-01 |
| Stage1-vs-Stage3 |
9.991400E-01 |
| Stage1-vs-Stage4 |
7.188400E-01 |
| Stage2-vs-Stage3 |
9.480600E-01 |
| Stage2-vs-Stage4 |
6.845000E-01 |
| Stage3-vs-Stage4 |
7.536800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.42379999976828E-07 |
| Normal-vs-AfricanAmerican |
8.423600E-04 |
| Normal-vs-Asian |
5.149000E-01 |
| Caucasian-vs-AfricanAmerican |
2.732200E-01 |
| Caucasian-vs-Asian |
4.933400E-01 |
| AfricanAmerican-vs-Asian |
5.942600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.23969999999718E-05 |
| Normal-vs-Female |
9.01029999944569E-07 |
| Male-vs-Female |
2.320200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.799600E-03 |
| Normal-vs-Extreme_Weight |
1.636450E-03 |
| Normal-vs-Obese |
1.152320E-04 |
| Normal-vs-Extreme_Obese |
3.965200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.500200E-01 |
| Normal_Weight-vs-Obese |
2.679400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.005800E-01 |
| Extreme_Weight-vs-Obese |
1.642230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.153800E-01 |
| Obese-vs-Extreme_Obese |
2.309000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.204300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.81039999447697E-08 |
| Normal-vs-Age(61-80Yrs) |
9.983200E-04 |
| Normal-vs-Age(81-100Yrs) |
6.820000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.932400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.643400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.563900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.938000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.319600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.41569999950941E-07 |
| Normal-VS-Type2 PRCC |
3.499800E-02 |
| Normal-VS-KIRP CIMP |
3.544200E-02 |
| Normal-VS-Unclassified PRCC |
1.637580E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.401170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.591800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.599400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.832500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.178300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.725200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.333700E-02 |
| Normal-vs-N1 |
1.647680E-02 |
| Normal-vs-N2 |
2.985800E-01 |
| N0-vs-N1 |
2.460000E-01 |
| N0-vs-N2 |
4.580400E-01 |
| N1-vs-N2 |
5.588800E-01 |
|
|
